{"SPADE_UN_19767": {"Sequence Information": {"Peptide Name": "Puroindoline-A (34-46)[K6,9,12R], PuroA [K6,9,12R]", "Sequence": "FPVTWRWWRWWRG", "Sequence Length": 13, "Biological Activity": ["Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P33432", "uniprotUrl": "http://www.uniprot.org/uniprot/P33432", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.", "Pubmed ID": "29671805", "Reference": "Biomolecules. 2018;8:E19", "Author": "Arias M, Piga KB, Hyndman ME, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29671805"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "Mass": 1919.2, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": -1.05, "Frequent Amino Acids": "WRF", "Absent Amino Acids": "ACDEHIKLMNOQSUY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 11, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_19767", "Similar Sequences": [{"SPADE_ID": "SPADE_N_09587", "Similarity": 1.0, "Sequence": "FPVLFPV"}, {"SPADE_ID": "SPADE_N_09589", "Similarity": 1.0, "Sequence": "FPVFPV"}, {"SPADE_ID": "SPADE_N_09592", "Similarity": 1.0, "Sequence": "FPVFPV"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=>=65 µM,Human PBMC:IC50=23.0 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=8-16µM),Jurkat T-cell leukemia(IC50=10.0µM)"}}}